| Tag | Content |
|---|
EnhancerAtlas ID | HS120-03734 |
Organism | Homo sapiens |
Tissue/cell | LNCaP-abl |
Coordinate | chr2:97554030-97554830 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF4 | MA0039.3 | chr2:97554509-97554520 | CCACACCCTCT | + | 6.02 | | Klf1 | MA0493.1 | chr2:97554507-97554518 | GGCCACACCCT | + | 6.32 | | SNAI2 | MA0745.2 | chr2:97554806-97554816 | AACAGGTGCA | + | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_04456 | chr2:97552812-97555300 | Brain_Anterior_Caudate | | SE_07778 | chr2:97552388-97555397 | Brain_Inferior_Temporal_Lobe | | SE_43421 | chr2:97552839-97555242 | MCF-7 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 97554154 | 97554683 | | chr2 | 97554424 | 97554532 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I096879 | chr2 | 97545691 | 97555230 |
|
Enhancer Sequence | CGGTTTCCTC CCAGCCCTCC TGACCTTGGC CTGACCAAGG TCCCCAGCCC AGTGGGGCAG 60
TAAGGAAGAG ACAGACACTT CCAGGTGGGA AGGCAGAGAG CATGGCGAGA ATGGAGAAAG 120
AGGCTCCACC TGCCTTTCAG GGGGACAGAG GGTAAGTGGC CTGTGCCCAG GGGAACACAT 180
GTCCCATTGC TGGAGTTGAG CATGCCAGCA AGAGAGGGCA GAGGCAAGCA CACAGCTGCC 240
AGAGGGCAGC GGCCCCCTCC CTGCCTAGCC CTGCAGTGAG AGCCAGGCCT TTCTCCACAA 300
CCTCCCATTA AGGCGGCCCT TGGCAGGGTC ACCCAGCACA GGGACAGACA ACTGCAGTTA 360
CAGCAGCGGG AGCGAAGCAG TAAAACTTGT TTGCCAACTC TATCAACACA CGCGGCACAC 420
CACAAGGATA TACAGGAGAT GTGCACAGCA CGCACTTATG CACAAACACA CAGCAGAGGC 480
CACACCCTCT GCAGAACATG AGCAGAGCTA CTCAGAATGA GCATGAACGC AGTGGAGTTG 540
GCACAGCTGG GCTGAGTTTA TCCCAGAGCA TCACCCAATC CCTGGAGCAC ACCCCCCCTC 600
CCCGCCAACA ACTCCATTCT GTACAAATGC ACTTCTCCAA TAAACAAGCC ACACATCCCC 660
AGGCCTCAGG AGCATGAGCT GGGGACCTTA AGTGGTGTGC ACCTCGAGAA AGCTGACTAG 720
AGCCACTCGC GCTCAGTCGG GGGCCTTGAT CTGGGTGGTG CCCCCGCAGG GACCATAACA 780
GGTGCAGAAC CCACAGACTG 800
|
